Statistics
Total Visits
| Views | |
|---|---|
| Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial | 296 |
Total Visits per Month
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial | 10 | 19 | 5 | 5 | 4 | 3 | 0 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 154 |
| Brazil | 31 |
| Vietnam | 17 |
| Argentina | 9 |
| China | 9 |
| Germany | 9 |
| Russia | 8 |
| Australia | 6 |
| United Kingdom | 5 |
| Czechia | 4 |
Top City Views
| Views | |
|---|---|
| Austin | 28 |
| Ashburn | 17 |
| Hanoi | 14 |
| San Mateo | 14 |
| Fairfield | 9 |
| San Diego | 6 |
| Ann Arbor | 4 |
| Des Moines | 4 |
| Dearborn | 3 |
| Portland | 3 |